Gabapentin Capsule
Product Images NDC 63187-988

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63187-988). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Image shows a pharmacokinetic formula for estimating creatinine clearance (CLCr). The formula calculates CLCr based on age, weight, sex adjustment factor, and serum creatinine level. This formula is typically used to assess kidney function relevant to dosing adjustments.*

FDA Label Image

1 (Image 11)

Gabapentin 300 mg capsules in a white box labeled with 'Gabapentin' and strength '300 mg.' The package shows a count of 100 capsules, includes the labeler name Proficient Rx LP, and features the Proficient brand logo in blue and orange. The design includes the text 'RX ONLY' indicating prescription use.*

FDA Label Image

63187-988-00 (Image 14)

Label for Gabapentin 300 mg capsules by Proficient Rx LP, showing prescription use with NDC 63187-988-00. The label notes each capsule contains 300 mg of Gabapentin USP and is a yellow and light brown capsule printed with logo 2666. Manufactured by Actavis Elizabeth LLC, Elizabeth, NJ, it includes storage instructions and warnings to keep out of reach of children.*

FDA Label Image

1 (Image 2)

Gabapentin 300 mg oral capsules bottle labeled by Proficient Rx LP. The amber plastic prescription bottle has a white child-resistant cap and a label displaying the product name Gabapentin with the strength 300 mg, dosage form capsules, and NDC 63187-988. The label includes additional prescription information and regulatory text.*

FDA Label Image

1 (Image 3)

Gabapentin 300 mg capsule bottle label from Proficient Rx LP with product name Gabapentin, strength 300 mg, oral capsule dosage form, and NDC 63187-988. The label includes dosing and manufacturer information on a white and orange background.*

FDA Label Image

1 (Image 4)

Gabapentin 300 mg oral capsules in a white bottle with a solid black flip-top cap. The label includes the Proficient Rx LP logo, and specifies the strength as 300 mg. The bottle likely contains a quantity of capsules, with text indicating the product is for prescription use.*

FDA Label Image

1 (Image 5)

Chemical structure diagram of Gabapentin, showing a cyclohexane ring bonded to two side chains: one with an amino group (CH2NH2) and the other with a carboxylic acid group (CH2CO2H).*

FDA Label Image

1 (Image 6)

A line graph comparing mean pain scores over an 8-week period for placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks, subdivided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. The graph shows a decrease in pain scores for Gabapentin over time, while placebo scores remain relatively constant.*

FDA Label Image

2 (Image 7)

A line graph depicting mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks including a 3-week dose titration and 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a decline in pain scores compared to placebo over time.*

FDA Label Image

3 (Image 8)

A bar chart comparing percentage outcomes in two studies labeled 'Study 1' and 'Study 2'. Study 1 shows 12% for placebo (PBO) and 29% for Gabapentin 3600 (GBP 3600). Study 2 displays 14% for placebo, 32% for Gabapentin 1800, and 34% for Gabapentin 2400. Statistical significance markers are included with p-values under 0.01 and 0.001.*

FDA Label Image

4 (Image 9)

A scatter plot chart showing the percentage difference on the y-axis versus daily dose in milligrams on the x-axis for Gabapentin studies. Data points represent three different studies labeled a, b, and c, with doses ranging from 600 mg to 1800 mg and differences between approximately 7% and 18%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.